365Phyta Core
Lot and status control, holds, sampling, waste, a full audit trail, electronic signatures with re-authentication and GS1 labels.
For companies that grow, make, hold or trade narcotics and psychotropics, with medical cannabis as the flagship. Licences and permits, counterparty qualification, quotas, a stock book to the gram, signed period close, a destruction register with witnesses and released-only distribution, in the ERP you already run.

An order cannot be released unless both parties hold a valid licence for the substance, and counterparties are qualified before they are used.
Per-shipment permits and their remaining balance are checked before an order is released.
Quotas are tracked against what you receive, make and ship, and checked before an order is released.
Every receipt, process use, sale, return and destruction posts to the stock book, which reconciles to the item ledger to the gram.
Each period is closed with an electronic signature, and the closed period is kept as signed.
Every destruction is recorded in the destruction register against the lot, with a second witness who must be a different person.
Regulated steps wait for the narcotics officer's electronic sign-off, with name, time and meaning recorded.
Regulatory reports come from the same stock book, and only released stock can be picked and shipped.
Medical cannabis is the most complete use case: cultivation from mother plant to harvest, processing, import and distribution, with four published bundles. Medical cannabis in detail.
Growing and exporting dried flower to EU-GMP processors.
Receiving bulk, decontaminating, packaging and releasing.
Holding narcotics licences and supplying pharmacies.
Growing, processing and exporting within one group.
Lot and status control, holds, sampling, waste, a full audit trail, electronic signatures with re-authentication and GS1 labels.
Licences and permits, counterparty qualification, the stock book to the gram, quotas, signed period close, the destruction register with witnesses, regulatory reporting and narcotics-officer sign-offs.
Mother plants, plant batches, input applications with pre-harvest intervals, environmental monitoring, harvest and grow log: the start of the medical cannabis chain.
Specifications, sampling plans, OOS and OOT handling, CoA verification, line clearance, deviations and CAPA, master and executed batch records, QP release and recall.
GDP distribution, FEFO and released-only picking, customer qualification, market pricing, SGTIN and SSCC serialisation, EPCIS event export.
Separate extensions per market: Germany (including PZN and German pharmacy pricing rules) and Portugal are in development. More country packs planned.
Sterile or aseptic manufacturing, connection to the EU FMD / EMVS hub, pharmacovigilance, clinical-trial management, retail point of sale and patient data. We say so up front, so you can plan the systems around 365Phyta.
No. It applies to any narcotic or psychotropic substance handled under licence. Medical cannabis is the most complete case, with cultivation, processing, import and distribution.
Yes. The stock book reconciles to the item ledger to the gram, for any period, and each period is closed with an electronic signature.
Every destruction is recorded against the lot with a second witness, who must be a different person from the one recording it.
No. A sales or purchase order cannot be released without valid licences on both sides, enough permit balance and quota.
Country packs for Germany and Portugal are in development. More country packs are planned.
It does not cover sterile or aseptic manufacturing, connect to the EU FMD or EMVS hub, handle pharmacovigilance or manage clinical trials. It has no retail point of sale and holds no patient data.
Medical cannabisGermany import permit, step by stepCountry packsCompliance, requirement by requirementPharmaceutical distribution (GDP)
30 minutes, from a licence and quota check on an order to a witnessed destruction and a signed period close.